Technology
Health
Biotechnology
ARCA biopharma
$6.909876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-0.29%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ARCA biopharma and other stocks, options, ETFs, and crypto commission-free!
About ABIO
ARCA biopharma, Inc. Common Stock, also called ARCA biopharma, is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. Read More The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
Employees
15
Headquarters
Westminster, Colorado
Founded
1992
Market Cap
7.58M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
59.17K
High Today
$7.15
Low Today
$6.90
Open Price
$6.98
Volume
20.55K
52 Week High
$23.04
52 Week Low
$4.73
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Medical
Pharmaceutical
US
North America
Price Paid on Robinhood
241% Higher
Right Now
Average Price Paid
$2.02
52 Week Low
$4.73
52 Week High
$23.04
ABIO Earnings
-$1.98
-$1.35
-$0.73
-$0.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, After Hours